Novavax Announces Management Promotions
January 13, 2014 at 14:50 PM EST
Novavax (NASDAQ: NVAX ) announced a number of promotions within its clinical operations group in preparation for expanded clinical trial activities in 2014 and 2015. Gregory M. Glenn, M.D. has been named Senior Vice President, Research and Development. Dr. Glenn joined Novavax in July 2010 as Senior Vice President, Chief
